Main Industry
Biotechnology
Main Product/Service
1. CHOptimax™
2. CHO-H01
3. CHO-V08
4. CHO-H02
5. CHO-H03
6. CHO-A04
2. CHO-H01
3. CHO-V08
4. CHO-H02
5. CHO-H03
6. CHO-A04
The content above was translated by Ai
Founded Year
2013
Unified Business No.
54170142
Status
Active
Number of Employees
20
Total Paid-in
Capital
2,140,105,000 (NT$)
Location of Company
Taiwan
, Taipei City
Exit Status
Emerging Stock Exchange(2017)
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Founded in March 2013, CHO Pharma, Inc. is dedicated to the application of innovative sugar platform technology to the development of new drugs and the treatment and detection of diseases associated with carbohydrates. Our vision is to become a leading biopharmaceutical company in the field of sugar molecular technology, and to develop new drugswith high efficacy and low side effects and accurate early detection methods to provide patients with more quality medical treatment through innovative research and development and professional technology.
The content above was translated by Ai
